4 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic MastocytosisMast Cell Activation Disorders, Mastocytosis, Systemic, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, immune system disorder, indolent systemic mastocytosis, mastocytosis, neoplasmRecruitingPhase 2 / Phase 32026-10-07NCT04910685
An Evaluation of Multisense® to Ensure a Safe Return Home Following High-risk Gastrointestinal Surgery, Compared With Standard Care.Reduction in the Initial Length of StayRecruitingNot applicable2026-09-09NCT07552805
Diagnostic and Prognostic Evaluation of Vasorin During Septic ShockInfections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndromeRecruitingNot applicable2026-01-07NCT07203833
Automatic Detection of Eligible Patients to RAUC Protocol (RAUCISABLE)Emergency Department VisitRecruitingNot stated2025-06-25NCT07037719